Follow
Daniel Speidel
Daniel Speidel
Managing Director, Breakpoint Therapeutics GmbH
Verified email at breakpointtx.com
Title
Cited by
Cited by
Year
Transcription-independent pro-apoptotic functions of p53
UM Moll, S Wolff, D Speidel, W Deppert
Current opinion in cell biology 17 (6), 631-636, 2005
6542005
Transcription-independent p53 apoptosis: an alternative route to death
D Speidel
Trends in cell biology 20 (1), 14-24, 2010
4122010
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
M Michaelis, F Rothweiler, S Barth, J Cinatl, M Van Rikxoort, ...
Cell death & disease 2 (12), e243-e243, 2011
1842011
The role of DNA damage responses in p53 biology
D Speidel
Archives of toxicology 89 (4), 501-517, 2015
1812015
Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells
EL Kim, R Wüstenberg, A Rübsam, C Schmitz-Salue, G Warnecke, ...
Neuro-oncology 12 (4), 389-400, 2010
1742010
Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress
D Speidel, H Helmbold, W Deppert
Oncogene 25 (6), 940-953, 2006
952006
Inhibition of casein kinase I delta alters mitotic spindle formation and induces apoptosis in trophoblast cells
M Stöter, AM Bamberger, B Aslan, M Kurth, D Speidel, T Löning, ...
Oncogene 24 (54), 7964-7975, 2005
912005
Mutant p53R270H gain of function phenotype in a mouse model for oncogene‐induced mammary carcinogenesis
C Heinlein, F Krepulat, J Löhler, D Speidel, W Deppert, GV Tolstonog
International journal of cancer 122 (8), 1701-1709, 2008
842008
Gadd45β is a pro-survival factor associated with stress-resistant tumors
A Engelmann, D Speidel, GW Bornkamm, W Deppert, C Stocking
Oncogene 27 (10), 1429-1438, 2008
452008
Mutations in SIPA1L3 cause eye defects through disruption of cell polarity and cytoskeleton organization
R Greenlees, M Mihelec, S Yousoof, D Speidel, SK Wu, S Rinkwitz, ...
Human molecular genetics 24 (20), 5789-5804, 2015
412015
A rapid and optimization-free procedure allows the in vivo detection of subtle cell cycle and ploidy alterations in tissues by flow cytometry
C Heinlein, W Deppert, A Braithwaite, D Speidel
Cell Cycle 9 (17), 3584-3590, 2010
352010
Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents
M Michaelis, F Rothweiler, B Agha, S Barth, Y Voges, N Löschmann, ...
Cell death & disease 3 (4), e294-e294, 2012
342012
HOXB4 inhibits cell growth in a dose-dependent manner and sensitizes cells towards extrinsic cues
E Will, D Speidel, Z Wang, G Ghiaur, A Rimek, B Schiedlmeier, ...
Cell cycle 5 (1), 14-22, 2006
312006
Cellular stress responses in cancer and cancer therapy
M Chircop, D Speidel
Frontiers in oncology 4, 304, 2014
272014
Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant
TL Slatter, N Hung, S Bowie, H Campbell, C Rubio, D Speidel, M Wilson, ...
Cell death & disease 6 (6), e1783-e1783, 2015
262015
Resistance acquisition to MDM2 inhibitors
J Cinatl, D Speidel, I Hardcastle, M Michaelis
Biochemical Society transactions 42 (4), 752-757, 2014
252014
RUNX1 upregulation by cytotoxic drugs promotes apoptosis
D Speidel, J Wellbrock, M Abas
Cancer Research 77 (24), 6818-6824, 2017
102017
High‐resolution cell cycle and DNA ploidy analysis in tissue samples
C Heinlein, D Speidel
Current protocols in cytometry 56 (1), 7.39. 1-7.39. 11, 2011
92011
TP53 mutations and drug sensitivity in acute myeloid leukaemia cells with acquired MDM2 inhibitor resistance
M Michaelis, C Schneider, F Rothweiler, T Rothenburger, M Mernberger, ...
bioRxiv, 404475, 2018
32018
Molecular mechanisms of cellular stress responses in cancer and their therapeutic implications
M Chircop, D Speidel
Frontiers Media SA, 2015
22015
The system can't perform the operation now. Try again later.
Articles 1–20